Has Donald Page received payments from drug or device companies?

Yes. Drug and device makers reported $3,088 in general payments to Donald Page across 133 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Donald Page did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Donald Page come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Donald Page

Cardiovascular Disease · Marietta, GANPI 1184692899

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,258 and has fallen 97.8% since, to $28 in 2024.

$3,088in general payments, 2019–2025

Across 133 payments — averaging $23.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$605
Novartis$395
Johnson & Johnson$269
Boehringer Ingelheim$229
E.r. Squibb & Sons, L.L.C.$203
W. L. Gore & Associates, Inc.$181
plus $1K from 16 others

What the payments were for

Food & beverage$3,07099%
Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	10	$605
Novartis	19	$395
Johnson & Johnson	15	$269
Boehringer Ingelheim	12	$229
E.r. Squibb & Sons, L.L.C.	16	$203
W. L. Gore & Associates, Inc.	7	$181
Boston Scientific	6	$172
Abbott	2	$168
Amgen	6	$132
AstraZeneca	7	$118
Amarin Pharma, Inc.	9	$115
Teleflex LLC	1	$99
Pfizer	6	$94
Merck	4	$72
Bayer	2	$46
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$41
Esperion Therapeutics, Inc.	2	$33
Gilead	2	$33
Sanofi-aventis U.S. LLC	2	$28
Lundbeck LLC	1	$20
Novo Nordisk	1	$20
Chiesi USA, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,088 in reported general payments places this provider in the 55th percentile of 640 cardiovascular disease providers in Georgia.

See all cardiovascular disease providers in Georgia →

Other cardiovascular disease in Marietta

Dhaval PatelMarietta$67K
George KramerMarietta$55K
Narendra SinghJohns Creek$1.6M
Hunter ChampionColumbus$1.5M
Nicolas ChronosEatonton$912K
Jaime BurkleGainesville$628K
Joseph MillerAtlanta$573K
Kashyap ChoksiThomasville$263K
Utpal PandyaAtlanta$221K
Randolph MartinAtlanta$177K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →